Lv12
40 积分 2024-05-08 加入
EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axis
4小时前
待确认
Discovery of Dual Lysine Methyltransferase G9a and EZH2 Inhibitors with In Vivo Efficacy against Malignant Rhabdoid Tumor
5小时前
已完结
Fluorinated BPA derivatives enhanced 10B delivery in tumors
6天前
已完结
BNCT Pancreatic Cancer Treatment Strategy with glucose-conjugated boron drug
7天前
已完结
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
9天前
已完结
EZH2/G9a interact to mediate drug resistance in non-small-cell lung cancer by regulating the SMAD4/ERK/c-Myc signaling axis
11天前
已完结
Reserpine, a novel N6-methyladenosine regulator, reverses Lenvatinib resistance in hepatocellular carcinoma
14天前
已完结
Can public health policies on alcohol and tobacco reduce a cancer epidemic? Australia's experience
15天前
已完结
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region
15天前
已完结
Design, synthesis and evaluation of the novel chalcone derivatives with 2,2-dimethylbenzopyran as HIF-1 inhibitors that possess anti-angiogenic potential
1个月前
已完结
皖公网安备34019202002308
